Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ C. botulinum BoNT-C1 Heavy Chain Monoclonal Antibody (580223)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA524261

Catalog No. PIMA524261


Only null left
Add to Cart

Description

Description

Reconstitute in sterile PBS to a final concentration of 0.5 mg/mL.

Botulinum neurotoxin type A is one of the seven serotypes of Botulinum Neurotoxins (BoNTs) produced by various strains of Clostridium botulinum. BoNTs are synthesized as inactive single chain protein precursors and activated by proteolytic cleavage to generate disulfide-linked two-chain proteins. The 50 kDa light chain contains the catalytic domain, whereas the 100 kDa heavy chain contains an internal translocation domain and a receptor binding domain. BoNTs are the most potent protein toxins for humans. As zinc proteases, they cleave SNARE proteins to elicit flaccid paralysis in botulism by blocking acetylcholine release at the neuromuscular junction. E. coli-expressed recombinant light chains are active proteases. However, they are not toxic because they cannot enter into host cells in the absence of the heavy chains.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

C. botulinum BoNT-C1 Heavy Chain
Monoclonal
0.5 mg/mL
PBS with 5% trehalose and No Preservative
Mouse
Protein A/G
RUO
Bacteria
Antibody
IgG1
Immunoprecipitation, Western Blot
580223
Unconjugated
BONTC1
E. coli-derived recombinant C. botulinum BoNT-C1 Heavy Chain Asn866-Glu1291.
100 μg
Primary
-20°C, Avoid Freeze/Thaw Cycles
Lyophilized
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.